KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeresNazario Bosco, Teresa Davoli|Cell|2023Cited by 69
Proteogenomic insights suggest druggable pathways in endometrial carcinomaYongchao Dou, Mehdi Mesri, Lizabeth Katsnelson et al.|Cancer Cell|2023Cited by 53
Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 InductionXin Zhao, Scott M. Lippman, Raymond J. Lim et al.|Journal of Thoracic Oncology|2024Cited by 12